@justafarmwitch.bsky.social
Reposted
These French guidelines are sober, reasonable, comprehensive, and in line with the reality of pediatric treatment, where off-label prescribing and clinical judgement often plays a role in guidelines formation because of the ethical difficulties in enrolling minors in large randomized trials.
France has just had a review of healthcare for young trans people and it has come out entirely the opposite to Cass. But then again the personnel involved had not been specifically selected to arrive at a politically-required outcome.
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
![The most recent international guidelines [12] suggest that GAH should be initiated in transgender adolescents whose gender incongruence has been confirmed according to the criteria outlined in the ICD-11 (Table 1). Additionally, these adolescents should demonstrate sufficient emotional and cognitive maturity to provide informed consent for treatment. Unlike strict age criteria, other factors such as the duration of gender incongruence, medical follow-up history, persistence of transition requests, psychological distress, and the individual's maturity level should be considered when determining the optimal timing for introducing GAH.
In situations where GAH is introduced before Tanner stage 5 (especially when GnRHa has been previously prescribed), suppression can be maintained upon the introduction of GAH to prevent the action of endogenous hormones and the appearance or continued progression of secondary sexual characteristics in the undesired gender.](https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:d56idxm2oyqwwn2uxnegm2yo/bafkreicxk5xed5no2jm57oz6mzrtrenufehvmqn7ig4cqrgdeuiu52hqwu@jpeg)
December 3, 2024 at 3:23 PM
These French guidelines are sober, reasonable, comprehensive, and in line with the reality of pediatric treatment, where off-label prescribing and clinical judgement often plays a role in guidelines formation because of the ethical difficulties in enrolling minors in large randomized trials.